"Affordability remains a big concern for Indian ophthalmology market"

Currently, India faces a growing eye-health concern with approximately 4.95 million blind persons and 70 million vision-impaired individuals, including 240,000 blind children.

- Dr Manbeena Chawla

Dipu Bose, Head, Medical Technology, ZEISS India & Neighbouring Markets, India

Thus, the early detection and treatment of leading causes of blindness, such as cataracts, diabetes retinopathy and retinopathy of pre-term babies are crucial in reducing the prevalence of blindness and vision impairment across the country. Addressing this major concern, Germany headquartered technology firm ZEISS is collaborating with the Indian Institute of Science (IISc) in Bengaluru to harness the transformative potential of artificial intelligence (AI) to enhance eye-care research and practices. To know more about the company's plans towards strengthening eye care research in India, BioSpectrum connected with Dipu Bose - Head, Medical Technology, ZEISS India & Neighbouring Markets. Edited excerpts;

What are the major in-store plans at ZEISS for the Indian ophthalmology market in 2025?

ZEISS India continues to deepen its presence in the existing Indian subcontinent, leveraging advanced technologies like AI, robotics, and digital solutions to enhance clinical procedures and deliver superior patient outcomes. For many people, health is the most valuable asset. In recent decades, advances in medicine and technology as well as growing prosperity have increased life expectancy and improved the health of people around the world and is no different in India and ZEISS is committed to support clinical community to improve eye care across India and focusing on improving our reach and distribution into smaller towns of the country.